ADCT · Company research
ADC Therapeutics SA (ADCT): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| ADC Therapeutics: Shares Spike On Restructuring, But Safety Fears Undermine Bull Thesis - Seeking Alpha | ADC Therapeutics: Shares Spike On Restructuring, But Safety Fears Undermine Bull Thesis Seeking Alpha | View source ↗ | Seeking Alpha | Oct 9, 2026 | neutral | 0 | 0.6 |
| An $86.6 million financing is expected to keep ADC Therapeutics funded into 2029. - Stock Titan | An $86.6 million financing is expected to keep ADC Therapeutics funded into 2029. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Zynlonta Outlook - Yahoo Finance | ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Zynlonta Outlook Yahoo Finance | View source ↗ | Yahoo Finance | Aug 15, 2026 | neutral | 0 | 0.6 |
| ADC Therapeutics (ADCT) Stock Faces LOTIS 5 Doubts Despite Narrower Loss - Simply Wall Street | ADC Therapeutics (ADCT) Stock Faces LOTIS 5 Doubts Despite Narrower Loss Simply Wall Street | View source ↗ | Simply Wall Street | Aug 14, 2026 | neutral | 0 | 0.6 |
| ADC THERAPEUTICS SA -REDH ($ADCT) Releases Q2 2026 Earnings | ADCT Stock News - Quiver Quantitative | ADC THERAPEUTICS SA -REDH ($ADCT) Releases Q2 2026 Earnings | ADCT Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 13, 2026 | neutral | 0 | 0.6 |
| $ADCT stock is down 17% today. Here's what we see in our data. - Quiver Quantitative | $ADCT stock is down 17% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 13, 2026 | neutral | 0 | 0.6 |
| $ADCT stock is up 9% today. Here's what we see in our data. - Quiver Quantitative | $ADCT stock is up 9% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 7, 2026 | neutral | 0 | 0.6 |
| ADC Therapeutics gives new hire 17,000-share inducement award - Stock Titan | ADC Therapeutics gives new hire 17,000-share inducement award Stock Titan | View source ↗ | Stock Titan | Jul 1, 2026 | neutral | 0 | 0.6 |
| ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Analyst Views - Yahoo Finance | ADC Therapeutics (ADCT) Stock Fair Value Falls After LOTIS 5 Reshapes Analyst Views Yahoo Finance | View source ↗ | Yahoo Finance | Jun 27, 2026 | neutral | 0 | 0.6 |
| ADCT Forecast — Price Target — Prediction for 2027 - TradingView | ADCT Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| ADC Therapeutics trims 17% of staff to fund ZYNLONTA push - Stock Titan | ADC Therapeutics trims 17% of staff to fund ZYNLONTA push Stock Titan | View source ↗ | Stock Titan | Jun 24, 2026 | neutral | 0 | 0.6 |
| ADC Therapeutics (ADCT) Is Down 69.7% After Mixed LOTIS-5 ZYNLONTA Data - Has The Bull Case Changed? - Yahoo Finance | ADC Therapeutics (ADCT) Is Down 69.7% After Mixed LOTIS-5 ZYNLONTA Data - Has The Bull Case Changed? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 7, 2026 | neutral | 0 | 0.6 |
| Why Is ADC Therapeutics Stock Falling On Friday? - ADC Therapeutics (NYSE:ADCT) - Benzinga | Why Is ADC Therapeutics Stock Falling On Friday? - ADC Therapeutics (NYSE:ADCT) Benzinga | View source ↗ | Benzinga | Jun 5, 2026 | neutral | 0 | 0.6 |
| ADCT Stock Plunges on Safety Concerns Despite Positive Lymphoma Data - Yahoo Finance | ADCT Stock Plunges on Safety Concerns Despite Positive Lymphoma Data Yahoo Finance | View source ↗ | Yahoo Finance | Jun 4, 2026 | neutral | 0 | 0.6 |
| ADC Therapeutics plunges after patient deaths in blood cancer drug trial - Reuters | ADC Therapeutics plunges after patient deaths in blood cancer drug trial Reuters | View source ↗ | Reuters | Jun 4, 2026 | neutral | 0 | 0.6 |
| Zynlonta combo slows lymphoma progression to 6.1 months vs 4.7 in Phase 3 LOTIS-5 - Stock Titan | Zynlonta combo slows lymphoma progression to 6.1 months vs 4.7 in Phase 3 LOTIS-5 Stock Titan | View source ↗ | Stock Titan | Jun 3, 2026 | neutral | 0 | 0.6 |
| ADC Therapeutics SA (ADCT) Stock Price: Oct 6 Close $1.27 - Gotrade | ADC Therapeutics SA (ADCT) Stock Price: Oct 6 Close $1.27 Gotrade | View source ↗ | Gotrade | Feb 2, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.